ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,303.27
      0.12%
      US Tech 100
      18,062.00
      -0.10%
      Dow Jones
      40,003.59
      0.34%
      Brent Oil
      83.76
      0.00%
      Bitcoin
      67,234.80
      0.44%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Corcept Therapeutics Inc (CORT)

      7. Corcept Therapeutics Inc (CORT) News

      CORT

      Corcept Therapeutics (CORT)

      Corcept Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:CORT
      DateTimeSourceHeadlineSymbolCompany
      05/15/20248:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
      05/13/20249:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
      05/13/202412:24PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CORTCorcept Therapeutics Inc
      05/09/202412:35PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CORTCorcept Therapeutics Inc
      05/06/20248:23PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
      05/01/20244:05PMGlobeNewswire Inc.Corcept Therapeutics Announces First Quarter Financial Results and Provides Corporate UpdateNASDAQ:CORTCorcept Therapeutics Inc
      04/29/20248:00AMGlobeNewswire Inc.Corcept Completes Enrollment in Phase 4 CATALYST TrialNASDAQ:CORTCorcept Therapeutics Inc
      04/24/20244:05PMGlobeNewswire Inc.Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference CallNASDAQ:CORTCorcept Therapeutics Inc
      04/22/20248:00AMGlobeNewswire Inc.Corcept Announces Positive Results From Open-Label Portion of Pivotal Phase 3 GRACE Trial in Patients With Cushing’s SyndromeNASDAQ:CORTCorcept Therapeutics Inc
      04/15/20248:00AMGlobeNewswire Inc.Corcept Completes Enrollment in Phase 2 DAZALS Trial in Patients With Amyotrophic Lateral Sclerosis (ALS)NASDAQ:CORTCorcept Therapeutics Inc
      04/08/20248:00AMGlobeNewswire Inc.Corcept Completes Enrollment in Pivotal Phase 3 Rosella Trial of Relacorilant in Patients With Platinum-Resistant Ovarian CancerNASDAQ:CORTCorcept Therapeutics Inc
      04/01/20248:00AMGlobeNewswire Inc.Corcept Completes Enrollment in Phase 3 Gradient Trial of Relacorilant in Patients With Adrenal Cushing’s SyndromeNASDAQ:CORTCorcept Therapeutics Inc
      03/05/20249:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
      03/05/20249:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
      03/05/20249:09PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
      03/05/20249:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
      03/05/20249:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
      03/05/20248:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
      03/01/20245:24PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CORTCorcept Therapeutics Inc
      02/21/20249:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
      02/20/20248:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
      02/16/202412:12PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CORTCorcept Therapeutics Inc
      02/15/20244:17PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CORTCorcept Therapeutics Inc
      02/15/20244:11PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CORTCorcept Therapeutics Inc
      02/15/20244:07PMGlobeNewswire Inc.Corcept Therapeutics Announces Fourth Quarter and Full-Year 2023 Audited Financial Results and Provides Corporate UpdateNASDAQ:CORTCorcept Therapeutics Inc
      02/15/20244:02PMGlobeNewswire Inc.Corcept Announces Preliminary Results From Prevalence Phase Of CATALYST Clinical TrialNASDAQ:CORTCorcept Therapeutics Inc
      02/15/20243:45PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CORTCorcept Therapeutics Inc
      02/14/20244:23PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CORTCorcept Therapeutics Inc
      02/13/20248:47PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
      02/13/20248:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:CORT